These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18000219)

  • 41. Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.
    Huber M; Bahr I; Krätzschmar JR; Becker A; Müller EC; Donner P; Pohlenz HD; Schneider MR; Sommer A
    Mol Cell Proteomics; 2004 Jan; 3(1):43-55. PubMed ID: 14557597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.
    Salazar MD; Ratnam M; Patki M; Kisovic I; Trumbly R; Iman M; Ratnam M
    Breast Cancer Res; 2011 Feb; 13(1):R18. PubMed ID: 21299862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.
    Reijm EA; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; van Gelder ME; Sieuwerts AM; Sleijfer S; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2011 Jan; 125(2):387-94. PubMed ID: 20306127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
    Creighton CJ; Massarweh S; Huang S; Tsimelzon A; Hilsenbeck SG; Osborne CK; Shou J; Malorni L; Schiff R
    Cancer Res; 2008 Sep; 68(18):7493-501. PubMed ID: 18794137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
    Godinho M; Meijer D; Setyono-Han B; Dorssers LC; van Agthoven T
    J Cell Physiol; 2011 Jul; 226(7):1741-9. PubMed ID: 21506106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI.
    Mao C; Livezey M; Kim JE; Shapiro DJ
    Sci Rep; 2016 Oct; 6():34753. PubMed ID: 27713477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
    Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
    Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
    Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
    Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
    Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
    BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
    Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
    Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
    Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
    Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
    Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
    Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Hockings JK; Degner SC; Morgan SS; Kemp MQ; Romagnolo DF
    Breast Cancer Res; 2008; 10(2):R29. PubMed ID: 18377656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activating
    Toy W; Weir H; Razavi P; Lawson M; Goeppert AU; Mazzola AM; Smith A; Wilson J; Morrow C; Wong WL; De Stanchina E; Carlson KE; Martin TS; Uddin S; Li Z; Fanning S; Katzenellenbogen JA; Greene G; Baselga J; Chandarlapaty S
    Cancer Discov; 2017 Mar; 7(3):277-287. PubMed ID: 27986707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aromatase promoter I.f is regulated by estrogen receptor alpha (ESR1) in mouse hypothalamic neuronal cell lines.
    Yilmaz MB; Wolfe A; Cheng YH; Glidewell-Kenney C; Jameson JL; Bulun SE
    Biol Reprod; 2009 Nov; 81(5):956-65. PubMed ID: 19605792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials.
    Najim O; Seghers S; Sergoynne L; Van Gaver H; Papadimitriou K; Wouters K; Trinh XB; Huizing MT; Tjalma W
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188315. PubMed ID: 31647985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.
    Hiscox S; Jordan NJ; Jiang W; Harper M; McClelland R; Smith C; Nicholson RI
    Endocr Relat Cancer; 2006 Dec; 13(4):1085-99. PubMed ID: 17158755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells.
    Garofalo C; Sisci D; Surmacz E
    Clin Cancer Res; 2004 Oct; 10(19):6466-75. PubMed ID: 15475434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preexisting Somatic Mutations of Estrogen Receptor Alpha (
    Dahlgren M; George AM; Brueffer C; Gladchuk S; Chen Y; Vallon-Christersson J; Hegardt C; Häkkinen J; Rydén L; Malmberg M; Larsson C; Gruvberger-Saal SK; Ehinger A; Loman N; Borg Å; Saal LH
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33937624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.